About Tenet Healthcare Corporation (NYSE:THC)
Tenet Healthcare Corporation (Tenet) is a healthcare services company. The Company operates regionally focused, integrated healthcare delivery networks in large urban and suburban markets in the United States. The Company's segments include Hospital Operations and Other, Ambulatory Care and Conifer. As of December 31, 2016, its subsidiaries operated 79 hospitals, including three academic medical centers, two children's hospitals, two specialty hospitals and one critical access hospital. The Company's Ambulatory Care segment includes the operations of its USPI joint venture and its Aspen facilities. As of December 31, 2016, Conifer provided one or more of the business process services described above from 20 service centers to more than 800 Tenet and non-Tenet hospital and other clients in over 40 states. As of December 31, 2016, the Company operated 20 short-stay surgical hospitals, over 470 outpatient centers, and nine facilities in the United Kingdom.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Healthcare Facilities & Services
- Sub-Industry: Health Care Facilities
- Symbol: NYSE:THC
- CUSIP: 88033G40
- Web: www.tenethealth.com
Capitalization:- Market Cap: $1.48 billion
- Outstanding Shares: 100,820,000
Average Prices:- 50 Day Moving Avg: $15.64
- 200 Day Moving Avg: $16.92
- 52 Week Range: $12.25 - $24.13
P/E:- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 11.94
- P/E Growth: 1.24
Sales & Book Value:- Annual Revenue: $19.32 billion
- Price / Sales: 0.08
- Book Value: $3.70 per share
- Price / Book: 3.97
Profitability:- EBITDA: $2.07 billion
- Net Margins: -0.97%
- Return on Equity: -2.00%
- Return on Assets: -0.09%
Debt:- Debt-to-Equity Ratio: 14.23%
- Current Ratio: 1.24%
- Quick Ratio: 1.17%
Misc:- Average Volume: 4.56 million shs.
- Beta: 1.2
- Short Ratio: 9.62
Frequently Asked Questions for Tenet Healthcare Corporation (NYSE:THC)
What is Tenet Healthcare Corporation's stock symbol?
Tenet Healthcare Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "THC."
How were Tenet Healthcare Corporation's earnings last quarter?
Tenet Healthcare Corporation (NYSE:THC) announced its earnings results on Monday, August, 7th. The company reported ($0.17) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.17). The firm earned $14.80 billion during the quarter, compared to analysts' expectations of $4.90 billion. Tenet Healthcare Corporation had a negative return on equity of 2.00% and a negative net margin of 0.97%. The company's revenue was up 204.1% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.38 earnings per share. View Tenet Healthcare Corporation's Earnings History.
When will Tenet Healthcare Corporation make its next earnings announcement?
What guidance has Tenet Healthcare Corporation issued on next quarter's earnings?
Tenet Healthcare Corporation issued an update on its FY17 earnings guidance on Monday, August, 7th. The company provided earnings per share guidance of $0.69-0.99 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.20. The company issued revenue guidance of $19.1-19.4 billion, compared to the consensus revenue estimate of $19.74 billion.
Where is Tenet Healthcare Corporation's stock going? Where will Tenet Healthcare Corporation's stock price be in 2017?
15 analysts have issued 1 year price objectives for Tenet Healthcare Corporation's stock. Their forecasts range from $14.00 to $30.00. On average, they anticipate Tenet Healthcare Corporation's share price to reach $20.31 in the next twelve months. View Analyst Ratings for Tenet Healthcare Corporation.
What are analysts saying about Tenet Healthcare Corporation stock?
Here are some recent quotes from research analysts about Tenet Healthcare Corporation stock:
- 1. According to Zacks Investment Research, "Tenet Healthcare’s shares have underperformed the industry in last one year. The company has a high level of uncollectible accounts despite several divestures. Rising level of bad debts over past few quarters has led to a spike in interest expenses that has been weighing on the margins. Its operating expenses have also been rising rapidly putting pressure on the bottom line. The company has seen its Zacks Consensus Estimate for 2017 and 2018 earnings being revised downward in last 60 days. Following the lackluster second-quarter 2017 results, the company has lowered its guidance for 2017." (9/19/2017)
- 2. Mizuho analysts commented, "Part of the job of an analyst is to connect disparate pieces of information in order to validate, reject or create an investment thesis. We connect THC's January comments about cost cutting initiatives & potential asset sales with reports from Detroit & other markets regarding the possible depth, immediacy and impact of those cuts, CYH's recent success with the same strategy and then estimate the potential impact on EBITDA and valuation. The conclusion we reach is that our Underperform rating was no longer valid. We raise our rating to Neutral and our PT to $22.80 from $13." (2/24/2017)
Are investors shorting Tenet Healthcare Corporation?
Tenet Healthcare Corporation saw a decline in short interest in the month of September. As of September 29th, there was short interest totalling 29,815,244 shares, a decline of 14.2% from the September 15th total of 34,730,269 shares. Based on an average daily volume of 3,246,223 shares, the short-interest ratio is presently 9.2 days. Approximately 30.2% of the company's shares are sold short.
Who are some of Tenet Healthcare Corporation's key competitors?
Some companies that are related to Tenet Healthcare Corporation include Select Medical Holdings Corporation (SEM), LifePoint Health (LPNT), Udg Healthcare PLC (UDG), HMS Holdings Corp (HMSY), China Cord Blood Corporation (CO), HealthStream (HSTM), The Providence Service Corporation (PRSC), Community Health Systems (CYH), Kindred Healthcare (KND), Georgia Healthcare Group PLC (GHG), American Renal Associates Holdings (ARA), Cambian Group PLC (CMBN), Concord Medical Services Holdings Limited (CCM), Nobilis Health Corp (HLTH), The Joint Corp. (JYNT), Cancer Genetics (CGIX), Streamline Health Solutions (STRM) and Air Methods Corp (AIRM).
Who are Tenet Healthcare Corporation's key executives?
Tenet Healthcare Corporation's management team includes the folowing people:
- Ronald A. Rittenmeyer, Executive Chairman of the Board
- Trevor Fetter, President, Chief Executive Officer
- Daniel J. Cancelmi, Chief Financial Officer
- J. Eric Evans, President - Hospital Operations
- Audrey T. Andrews, Senior Vice President and General Counsel
- John P. Byrnes, Independent Director
- Brenda J. Gaines, Independent Director
- Karen M. Garrison, Independent Director
- Edward A. Kangas, Independent Director
- J. Robert Kerrey, Independent Director
Who owns Tenet Healthcare Corporation stock?
Tenet Healthcare Corporation's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include
GLENVIEW CAPITAL MANAGEMENT, LLC
(17.79%),
GLENVIEW CAPITAL MANAGEMENT, LLC
(17.79%),
CAMBER CAPITAL MANAGEMENT LLC
(5.70%), Nationwide Fund Advisors (0.19%) and Mutual of America Capital Management LLC (0.06%). Company insiders that own Tenet Healthcare Corporation stock include Glenview Capital Management, L, Peter M Wilver and Ronald A Rittenmeyer. View Institutional Ownership Trends for Tenet Healthcare Corporation.
Who sold Tenet Healthcare Corporation stock? Who is selling Tenet Healthcare Corporation stock?
Who bought Tenet Healthcare Corporation stock? Who is buying Tenet Healthcare Corporation stock?
Tenet Healthcare Corporation's stock was purchased by a variety of institutional investors in the last quarter, including Nationwide Fund Advisors. Company insiders that have bought Tenet Healthcare Corporation stock in the last two years include Glenview Capital Management, L, Peter M Wilver and Ronald A Rittenmeyer. View Insider Buying and Selling for Tenet Healthcare Corporation.
How do I buy Tenet Healthcare Corporation stock?
Shares of Tenet Healthcare Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Tenet Healthcare Corporation's stock price today?
One share of Tenet Healthcare Corporation stock can currently be purchased for approximately $14.69.
MarketBeat Community Rating for Tenet Healthcare Corporation (NYSE THC)MarketBeat's community ratings are surveys of what our community members think about Tenet Healthcare Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Tenet Healthcare Corporation (NYSE:THC) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 10 Hold Ratings, 5 Buy Ratings |
| Consensus Rating: | Hold (Score: 2.33) |
| Consensus Price Target: | $20.31 (38.24% upside) |
Consensus Price Target History for Tenet Healthcare Corporation (NYSE:THC)
Analysts' Ratings History for Tenet Healthcare Corporation (NYSE:THC)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 10/15/2017 | SunTrust Banks, Inc. | Set Price Target | Hold | $15.00 | N/A |  |
| 9/28/2017 | Robert W. Baird | Reiterated Rating | Buy | $23.00 | High | |
| 9/25/2017 | Royal Bank Of Canada | Reiterated Rating | Hold | $19.00 | High | |
| 9/21/2017 | Jefferies Group LLC | Reiterated Rating | Buy | $24.00 | Low | |
| 9/14/2017 | Mizuho | Reiterated Rating | Neutral | $14.00 | Medium | |
| 9/14/2017 | Citigroup Inc. | Reiterated Rating | Hold | $16.00 | Medium | |
| 9/1/2017 | Deutsche Bank AG | Reiterated Rating | Buy | $24.00 | Low | |
| 8/20/2017 | Leerink Swann | Reiterated Rating | Outperform | $23.00 -> $30.00 | High | |
| 8/9/2017 | Credit Suisse Group | Lower Price Target | Neutral | $20.00 -> $17.00 | Low | |
| 6/6/2017 | Morgan Stanley | Initiated Coverage | Equal -> Equal Weight | $19.00 | High | |
| 6/6/2017 | Wells Fargo & Company | Upgrade | Market Perform -> Outperform | $22.00 | Low | |
| 1/3/2017 | Piper Jaffray Companies | Initiated Coverage | Neutral | $16.00 | N/A | |
| 11/10/2016 | Raymond James Financial, Inc. | Downgrade | Outperform -> Market Perform | | N/A | |
| 11/9/2016 | Bank of America Corporation | Downgrade | Buy -> Neutral | $32.00 -> $25.00 | N/A | |
| 10/25/2016 | Wolfe Research | Initiated Coverage | Market Perform | | N/A | |
| 8/19/2016 | Barclays PLC | Reiterated Rating | Buy | $39.00 | N/A | |
| 6/13/2016 | Ladenburg Thalmann Financial Services | Upgrade | Not Rated -> Underperform | | N/A | |
| 5/16/2016 | Sterne Agee CRT | Reiterated Rating | Buy | | N/A | |
| 5/5/2016 | J P Morgan Chase & Co | Reiterated Rating | Hold | $36.00 | N/A | |
| 4/13/2016 | Susquehanna Bancshares Inc | Upgrade | Neutral -> Positive | $38.00 | N/A | |
| 2/26/2016 | BMO Capital Markets | Lower Price Target | Outperform | $55.00 -> $38.00 | N/A | |
(Data available from 10/23/2015 forward)
Earnings History for Tenet Healthcare Corporation (NYSE:THC)Earnings History by Quarter for Tenet Healthcare Corporation (NYSE THC)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 11/6/2017 | | ($0.37) | | | | | N/A | |
| 8/7/2017 | Q2 2017 | ($0.17) | ($0.17) | $4.90 billion | $14.80 billion | View | Listen | |
| 5/1/2017 | Q1 2017 | ($0.52) | ($0.27) | $4.84 billion | $4.81 billion | View | Listen | |
| 2/27/2017 | Q416 | $0.22 | $0.06 | $4.95 billion | $4.86 billion | View | N/A | |
| 10/31/2016 | Q316 | $0.17 | $0.16 | $2.28 billion | $4.85 billion | View | N/A | |
| 8/1/2016 | Q216 | $0.52 | $0.38 | $4.82 billion | $4.87 billion | View | N/A | |
| 5/2/2016 | Q116 | $0.34 | $0.45 | $4.79 billion | $5.04 billion | View | N/A | |
| 2/22/2016 | Q415 | $0.34 | $0.35 | $4.82 billion | $5.21 billion | View | Listen | |
| 11/2/2015 | Q315 | $0.27 | $0.29 | $4.67 billion | $4.69 billion | View | N/A | |
| 8/3/2015 | Q215 | $0.44 | $0.75 | $4.37 billion | $4.49 billion | View | N/A | |
| 5/4/2015 | Q115 | $0.31 | $0.67 | $4.33 billion | $4.43 billion | View | N/A | |
| 2/23/2015 | Q414 | $1.18 | $1.03 | $4.34 billion | $4.82 billion | View | N/A | |
| 11/3/2014 | Q314 | $0.10 | $0.09 | $4.02 billion | $4.18 billion | View | Listen | |
| 8/4/2014 | Q214 | $0.01 | ($0.27) | $3.94 billion | $4.04 billion | View | N/A | |
| 5/5/2014 | Q114 | ($0.14) | ($0.12) | $3.91 billion | $3.93 billion | View | Listen | |
| 2/24/2014 | Q413 | $0.37 | $0.49 | $3.87 billion | $3.89 billion | View | N/A | |
| 11/5/2013 | Q313 | $0.45 | $0.45 | $2.38 billion | $2.62 billion | View | Listen | |
| 8/6/2013 | Q2 2013 | $0.75 | ($0.49) | $2.46 billion | $2.42 billion | View | N/A | |
| 4/30/2013 | Q1 2013 | $0.31 | $0.33 | $2.46 billion | $2.59 billion | View | Listen | |
| 2/26/2013 | Q4 2012 | $0.68 | $0.45 | $2.34 billion | $2.33 billion | View | Listen | |
| 11/7/2012 | Q312 | $0.32 | $0.34 | $2.42 billion | $2.43 billion | View | N/A | |
| 8/7/2012 | | $0.05 | $0.10 | | | View | N/A | |
| 5/8/2012 | | $0.10 | $0.13 | | | View | N/A | |
| 2/28/2012 | | $0.14 | $0.10 | | | View | N/A | |
| 11/1/2011 | | | $0.04 | | | View | N/A | |
| 8/2/2011 | | $0.08 | $0.09 | | | View | N/A | |
| 5/3/2011 | | $0.14 | $0.17 | | | View | N/A | |
| 2/25/2011 | | $0.08 | $0.14 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Tenet Healthcare Corporation (NYSE:THC)2017 EPS Consensus Estimate: $0.95
2018 EPS Consensus Estimate: $1.99
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 5 | ($0.60) | $0.52 | ($0.32) |
| Q2 2017 | 5 | ($0.36) | $0.40 | $0.00 |
| Q3 2017 | 5 | ($0.46) | $0.37 | ($0.24) |
| Q4 2017 | 5 | $0.81 | $1.80 | $1.51 |
| Q1 2018 | 1 | $0.18 | $0.18 | $0.18 |
| Q2 2018 | 1 | $0.41 | $0.41 | $0.41 |
| Q3 2018 | 1 | $0.44 | $0.44 | $0.44 |
| Q4 2018 | 1 | $0.96 | $0.96 | $0.96 |
(Data provided by Zacks Investment Research)
Dividend History for Tenet Healthcare Corporation (NYSE:THC)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Tenet Healthcare Corporation (NYSE:THC)Insider Ownership Percentage: 3.10%
Insider Trades by Quarter for Tenet Healthcare Corporation (NYSE:THC)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 11/11/2016 | Ronald A Rittenmeyer | Director | Buy | 15,000 | $14.35 | $215,250.00 | |
| 11/9/2016 | Peter M Wilver | Director | Buy | 5,000 | $15.19 | $75,950.00 | |
| 11/13/2015 | Glenview Capital Management, L | Major Shareholder | Buy | 900,000 | $32.56 | $29,304,000.00 | |
| 10/22/2015 | Glenview Capital Management, L | Major Shareholder | Buy | 500,000 | $29.71 | $14,855,000.00 | |
| 9/30/2015 | Glenview Capital Management, L | Major Shareholder | Buy | 500,000 | $36.30 | $18,150,000.00 | |
| 8/25/2015 | Glenview Capital Management, L | Major Shareholder | Buy | 500,000 | $48.39 | $24,195,000.00 | |
| 7/14/2015 | Trevor Fetter | CEO | Sell | 96,477 | $60.40 | $5,827,210.80 | |
| 7/13/2015 | Trevor Fetter | CEO | Sell | 88,004 | $60.08 | $5,287,280.32 | |
| 7/6/2015 | Trevor Fetter | CEO | Sell | 83,443 | $60.02 | $5,008,248.86 | |
| 6/25/2015 | Glenview Capital Management, L | Major Shareholder | Buy | 979,482 | $54.93 | $53,802,946.26 | |
| 6/25/2015 | Trevor Fetter | CEO | Sell | 47,711 | $55.02 | $2,625,059.22 | |
| 6/4/2015 | R. Scott Ramsey | Insider | Sell | 5,650 | $51.64 | $291,766.00 | |
| 8/18/2014 | Trevor Fetter | CEO | Sell | 33,642 | $60.01 | $2,018,856.42 | |
| 8/14/2014 | Britt T Reynolds | Insider | Sell | 8,028 | $58.49 | $469,557.72 | |
| 8/8/2014 | Audrey T Andrews | SVP | Sell | 2,208 | $56.31 | $124,332.48 | |
| 8/8/2014 | Daniel J Cancelmi | CFO | Sell | 12,291 | $56.88 | $699,112.08 | |
| 8/8/2014 | R. Scott Ramsey | Insider | Sell | 2,083 | $56.27 | $117,210.41 | |
| 8/7/2014 | Trevor Fetter | CEO | Sell | 138,665 | $56.12 | $7,781,879.80 | |
| 7/25/2014 | Trevor Fetter | CEO | Sell | 41,000 | $51.34 | $2,104,940.00 | |
| 6/9/2014 | Britt T Reynolds | Insider | Sell | 35,000 | $49.82 | $1,743,700.00 | |
| 5/22/2014 | Trevor Fetter | CEO | Sell | 35,394 | $47.52 | $1,681,922.88 | |
| 5/15/2014 | Richard Pettingill | Director | Sell | 10,000 | $45.22 | $452,200.00 | |
| 5/12/2014 | Edward Kangas | Chairman | Sell | 12,000 | $44.29 | $531,480.00 | |
| 4/25/2014 | Trevor Fetter | CEO | Sell | 57,735 | $45.00 | $2,598,075.00 | |
| 3/24/2014 | Audrey Andrews | SVP | Sell | 13,624 | $40.17 | $547,276.08 | |
| 12/23/2013 | Glenview Capital Management, L | major shareholder | Buy | 248,910 | $39.79 | $9,904,128.90 | |
| 12/20/2013 | Glenview Capital Management, L | major shareholder | Buy | 644,582 | $39.95 | $25,751,050.90 | |
| 12/18/2013 | Glenview Capital Management, L | major shareholder | Buy | 1,000,000 | $40.12 | $40,120,000.00 | |
| 11/15/2013 | Keith Pitts | Chairman | Buy | 6,250 | $43.13 | $269,562.50 | |
| 11/14/2013 | Keith Pitts | Chairman | Buy | 6,250 | $43.14 | $269,625.00 | |
| 11/8/2013 | Keith Pitts | Chairman | Buy | 7,500 | $41.85 | $313,875.00 | |
| 11/7/2013 | Keith Pitts | Chairman | Buy | 5,000 | $41.97 | $209,850.00 | |
| 10/3/2013 | John Ellis Bush | Director | Sell | 16,582 | $45.10 | $747,848.20 | |
| 9/19/2013 | John Ellis Bush | Director | Sell | 8,291 | $42.90 | $355,683.90 | |
| 5/14/2013 | Glenview Capital Management, L | Major Shareholder | Sell | 4,000,000 | $47.75 | $191,000,000.00 | |
| 3/5/2013 | Edward A Kangas | Chairman | Sell | 7,000 | $39.88 | $279,160.00 | |
| 3/4/2013 | Trevor Fetter | CEO | Sell | 138,255 | $39.39 | $5,445,864.45 | |
| 10/19/2012 | Glenview Capital Management Ll | Major Shareholder | Buy | 200,000 | $23.53 | $4,706,000.00 | |
| 10/16/2012 | Glenview Capital Management Ll | Major Shareholder | Buy | 433,383 | $23.98 | $10,392,524.34 | |
| 9/17/2012 | Glenview Capital Management Ll | Major Shareholder | Buy | 750,000 | $5.75 | $4,312,500.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for Tenet Healthcare Corporation (NYSE:THC)
Latest Headlines for Tenet Healthcare Corporation (NYSE:THC)
| Source: |
|
Loading headlines, please wait.
Tenet Healthcare Corporation (THC) Chart for Monday, October, 23, 2017
